͵͵

Cancer

Gene-mutation pathway discovery paves way for targeted blood cancers therapies
News

Gene-mutation pathway discovery paves way for targeted blood cancers therapies

Nov. 3, 2024

A new study by researchers at the universities of Texas and Chicago explains the enzymatic activity that’s needed for tumor suppression in leukemias and other cancers.

Cholesterol synthesis and cancer
Journal News

Cholesterol synthesis and cancer

Aug. 27, 2024

Researchers find that the active form of a key cholesterol synthesis enzyme is upregulated in endometrial cancer tissues.

From the journals: JBC
Journal News

From the journals: JBC

July 19, 2024

Lung cancer cells resist ferroptosis. ORMDL3 in ulcerative colitis. Novel genetic variants in thyroid cancer. Read about these recent papers.

Radioactive drugs strike cancer with precision
News

Radioactive drugs strike cancer with precision

July 14, 2024

The tumor-seeking radiopharmaceuticals are charting a new course in oncology, with promise for targeted treatments with fewer side effects.

Scientists track 'doubling' in origin of cancer cells
News

Scientists track 'doubling' in origin of cancer cells

June 15, 2024

Researchers at Johns Hopkins say they have charted a molecular pathway that can lure cells down a hazardous path of duplicating their genome too many times.

From the journals: JLR
Journal News

From the journals: JLR

June 7, 2024

Switching cancer cells from pro- to antitumor. Species-specific skeletal muscle metabolism. Protein deletion improves metabolic disorders Read about recent papers on these topics.

'Protein sandwich' could transform cancer drug discovery
News

'Protein sandwich' could transform cancer drug discovery

June 1, 2024

A team led by Alessio Ciulli has defined a new class of so-called “intramolecular bivalent glue,” which binds proteins that would otherwise stay apart.

From the journals: MCP
Journal News

From the journals: MCP

March 29, 2024

Amino acids and sulfate signatures. Unveiling phosphatase substrates. Simplifying bacterial proteome profiling. Read about recent papers on these topics.

Focusing on a pivotal axis in chemoresistance
ASBMB Annual Meeting

Focusing on a pivotal axis in chemoresistance

March 24, 2024

Answers may lie in microRNA changes at the intersection of a cell cycle–regulating protein and a transcription factor that plays various roles in cancer.